Neumann R - Search Results

1

The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.

Schippinger W, Regitnig P, Bauernhofer T, Ploner F, Hofmann G, Krippl P, Wehrschütz M, Lax S, Carney W, Neumann R, Wernecke KD, Samonigg H. Schippinger W, et al. Among authors: neumann r. Oncol Rep. 2004 Jun;11(6):1331-6. Oncol Rep. 2004. PMID: 15138574

2

The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.

Schippinger W, Dandachi N, Regitnig P, Hofmann G, Balic M, Neumann R, Samonigg H, Bauernhofer T. Schippinger W, et al. Among authors: neumann r. Am J Clin Pathol. 2007 Oct;128(4):630-7. doi: 10.1309/51KPD70348RP6XTE. Am J Clin Pathol. 2007. PMID: 17875515

3

Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer.

Carney WP, Neumann R, Lipton A, Leitzel K, Ali S, Price CP. Carney WP, et al. Among authors: neumann r. Clin Chem. 2003 Oct;49(10):1579-98. doi: 10.1373/49.10.1579. Clin Chem. 2003. PMID: 14500583 Review.

4

Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.

Carney WP, Neumann R, Lipton A, Leitzel K, Ali S, Price CP. Carney WP, et al. Among authors: neumann r. Clin Breast Cancer. 2004 Jun;5(2):105-16. doi: 10.3816/cbc.2004.n.014. Clin Breast Cancer. 2004. PMID: 15245613 Review.

5

HER-2/neu diagnostics in breast cancer.

Carney WP, Leitzel K, Ali S, Neumann R, Lipton A. Carney WP, et al. Among authors: neumann r. Breast Cancer Res. 2007;9(3):207. doi: 10.1186/bcr1664. Breast Cancer Res. 2007. PMID: 17561991 Free PMC article.

6

Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients.

Bethune-Volters A, Labroquere M, Guepratte S, Hacene K, Neumann R, Carney W, Pichon MF. Bethune-Volters A, et al. Among authors: neumann r. Anticancer Res. 2004 Mar-Apr;24(2C):1083-9. Anticancer Res. 2004. PMID: 15154627 Free article.

7

Tissue expression and serum levels of the oncoprotein HER-2/neu in 157 primary breast tumours.

Pallud C, Guinebretiere JM, Guepratte S, Hacene K, Neumann R, Carney W, Pichon MF. Pallud C, et al. Among authors: neumann r. Anticancer Res. 2005 Mar-Apr;25(2B):1433-40. Anticancer Res. 2005. PMID: 15865102 Free article.

8

Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.

Kasimir-Bauer S, Schleucher N, Weber R, Neumann R, Seeber S. Kasimir-Bauer S, et al. Among authors: neumann r. Oncol Rep. 2003 Mar-Apr;10(2):475-82. Oncol Rep. 2003. PMID: 12579292

9

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.

Köstler WJ, Schwab B, Singer CF, Neumann R, Rücklinger E, Brodowicz T, Tomek S, Niedermayr M, Hejna M, Steger GG, Krainer M, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: neumann r. Clin Cancer Res. 2004 Mar 1;10(5):1618-24. doi: 10.1158/1078-0432.ccr-0385-3. Clin Cancer Res. 2004. PMID: 15014012

10

Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

Witzel I, Thomssen C, Krenkel S, Wilczak W, Bubenheim M, Pantel K, Neumann R, Jänicke F, Müller V. Witzel I, et al. Among authors: neumann r. Int J Biol Markers. 2006 Jul-Sep;21(3):131-40. doi: 10.1177/172460080602100301. Int J Biol Markers. 2006. PMID: 17013794 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

863 results

Search Page

Filters